NASDAQ · NEOG

Neogen Corp.

$9.40 -$0.21 (-2.19%) 1D After hours

Key Metrics

$2.09B
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow $6.11M
Beta · 1Y 1.40
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 15
    From its Feb 20 high, the share price fell 28%.

    Peak close $11.33 on Feb 20; trough close $8.19 on May 15. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -28%
  • Mar 6
    The stock moved -9.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.09B
Enterprise value$2.74B
Shares outstanding217.7M
52-wk range$4.56 – $11.43
Avg volume · 20D2.4M
Net cash −$652.70M
Book value / share$9.66
IndustryIn Vitro & In Vivo Diagnostic Substances
ExchangeNASDAQ
About Neogen Corp.
IPO dateAug 23, 1989
Employees1456

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF342.59
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio3.92
Quick ratio2.84
Debt / equity0.39
Debt / EBITDA
Net cash −$652.70M
Working capital$439.40M

Cash Flow · TTM

Operating CF $69.54M
Capex −$63.44M
Free cash flow $6.11M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-02-28 · computed by TickerWolf from SEC filings